查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1786432

全球心血管数位健康市场

Digital Health for Cardiovascular
出版日期: | 出版商: Global Industry Analysts, Inc. | 英文 282 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

简介目录

2030年，全球心血管数位健康市场规模将达到1,193亿美元

全球心血管数位健康市场规模预计在2024年达到419亿美元，预计2024年至2030年期间的复合年增长率为19.1%，到2030年将达到1193亿美元。软体组件是本报告分析的细分市场之一，预计其复合年增长率为17.0%，到分析期结束时规模将达到624亿美元。硬体组件细分市场在分析期间内的复合年增长率预计为22.1%。

美国市场规模将达 114 亿美元，中国市场预计复合年增长率为 25.5%

美国心血管数位健康市场规模预计在2024年达到114亿美元。作为世界第二大经济体，中国预计到2030年市场规模将达到274亿美元，在2024-2030年的分析期间内，复合年增长率为25.5%。其他值得关注的区域市场包括日本和加拿大，预计在分析期间内，这两个市场的复合年增长率分别为15.4%和16.9%。在欧洲，预计德国市场的复合年增长率约为15.9%。

全球心血管数位健康市场—主要趋势与驱动因素摘要

人工智慧和远端监控能减轻心血管疾病的负担吗？

数位健康解决方案与心血管护理的整合正在重塑心臟相关疾病的管理方式，它利用人工智慧 (AI)、远端患者监护(RPM) 和穿戴式技术提供对心血管健康的即时洞察。心血管疾病 (CVD) 仍然是全球死亡的主要原因，需要持续监测和早期疗育策略。主导的演算法现在可以分析心电图 (ECG)、检测心律不整并预测潜在的心臟疾病。智慧型手錶和连网心电图贴片等远端监控解决方案使医生无需频繁就医即可追踪心率变异性、血压和心律不整。人工智慧虚拟助理的兴起透过提供个人化建议、用药提醒和生活方式调整进一步提高了病人参与。虽然数位心血管解决方案可以加强早期发现和疾病管理，但监管部门核准、资料隐私问题和报销政策等挑战仍然是广泛采用的障碍。然而，随着人工智慧和远端监控技术的不断进步，它们将变得更加主动、数据驱动和可访问，从而改变心血管护理。

数位疗法 (DTx) 如何改善心血管结果？

数位疗法 (DTx) 提供基于证据的、软体主导的干预措施，补充传统疗法，并正在成为心血管疾病管理的有力工具。与典型的健康应用程式不同，DTx 解决方案经过临床检验，旨在针对特定的心血管风险因素，例如高血压、高胆固醇和肥胖。 Omada Health 和 Livongo 等公司正在开发基于人工智慧的数位辅导计划，帮助患者透过行为矫正策略管理与生活方式相关的风险因素。此外，与持续监测设备整合的数位疗法可提供即时警报和介入建议，以降低急性心臟事件的风险。向价值导向型医疗保健模式的转变也促使保险公司承保数位疗法，使患者更容易获得这些解决方案。然而，监管挑战、医生的犹豫以及长期临床检验的需求仍然是 DTx 解决方案在心血管护理领域扩展的障碍。随着研究不断证明其有效性，数位疗法有望成为心血管疾病预防和管理的核心组成部分。

人工智慧和巨量资料将在个人化心血管护理中发挥什么作用？

人工智慧和巨量资料分析在个人化心血管治疗计画中发挥越来越重要的作用，使基于个人遗传、代谢和生活方式因素的精准医疗方法成为可能。机器学习模型被用于分析大量数据集，包括电子健康记录(EHR)、遗传标记和患者报告数据，以确定心血管患者的个人化治疗途径。人工智慧主导的风险预测模型根据患者罹患心臟病的可能性进行分层，从而实现早期疗育和有针对性的预防措施。此外，人工智慧聊天机器人和远端医疗平台透过提供客製化建议和即时回答心血管健康咨询来提高病人参与。儘管人工智慧潜力巨大，但要充分发挥其在心血管医疗保健领域的潜力，需要解决人工智慧模型偏见、数据互通性问题以及监管部门核准需求等挑战。然而，随着巨量资料不断完善精准医疗方法，人工智慧有望在优化心血管治疗结果方面发挥重要作用。

是什么推动了心血管数位健康市场的成长？

心血管数位健康市场的成长受到多种因素的推动，包括心臟病患病率的上升、可穿戴医疗技术的普及以及主导诊断技术的进步。全球向远端医疗服务的转变推动了远端患者监护和家庭心臟护理的需求激增。监管机构也认识到数位健康介入的重要性，从而增加了对数位心血管解决方案的核准和报销支持。区块链与网路安全措施的整合正在加强病患资料的安全性，并提升人们对数位健康平台的信任。此外，精准医疗和个人化治疗方法的兴起，正推动医疗服务提供者在心血管护理领域采用人工智慧驱动的预测分析技术。对数位健康新兴企业的持续投资，以及科技公司、医疗服务提供者和保险公司之间的策略联盟，将推动数位心血管健康市场的显着成长，重塑心臟病管理的未来。

部分

组件（软体组件、硬体组件、服务组件）；最终用途（患者、提供者、付款人、其他）

受访公司范例

  • AliveCor
  • Amwell
  • Cardiogram
  • CardioSignal
  • Cardiovascular Health Solutions
  • Cleerly
  • DarioHealth
  • Eko
  • Fitbit
  • HeartFlow
  • Hello Heart
  • Idoven
  • Lark Health
  • Medtronic
  • Omron Healthcare
  • Philips Healthcare
  • Withings
  • Neko Health
  • Story Health
  • WellDoc

人工智慧集成

全球产业分析师利用可操作的专家内容和人工智慧工具改变市场和竞争情报。

Global Industry Analysts 没有遵循典型的 LLM 或特定于行业的 SLM查询，而是建立了一个从世界各地的专家收集的内容库，其中包括视频录像、博客、搜寻引擎研究以及大量的公司、产品/服务和市场数据。

关税影响係数

全球产业分析师根据公司总部所在国家、製造地和进出口（成品和原始设备製造商）情况预测其竞争地位的变化。这种复杂而多面的市场动态预计将以多种方式影响竞争对手，包括销货成本(COGS) 上升、盈利下降、供应链重组以及其他微观和宏观市场动态。

目录

第一章调查方法

第二章执行摘要

  • 市场概览
  • 主要企业
  • 市场趋势和驱动因素
  • 全球市场展望

第三章市场分析

  • 美国
  • 加拿大
  • 日本
  • 中国
  • 欧洲
  • 法国
  • 德国
  • 义大利
  • 英国
  • 西班牙
  • 俄罗斯
  • 其他欧洲国家
  • 亚太地区
  • 澳洲
  • 印度
  • 韩国
  • 其他亚太地区
  • 拉丁美洲
  • 阿根廷
  • 巴西
  • 墨西哥
  • 其他拉丁美洲
  • 中东
  • 伊朗
  • 以色列
  • 沙乌地阿拉伯
  • 阿拉伯聯合大公国
  • 其他中东地区
  • 非洲

第四章 比赛

简介目录
Product Code: MCP30497

Global Digital Health for Cardiovascular Market to Reach US$119.3 Billion by 2030

The global market for Digital Health for Cardiovascular estimated at US$41.9 Billion in the year 2024, is expected to reach US$119.3 Billion by 2030, growing at a CAGR of 19.1% over the analysis period 2024-2030. Software Component, one of the segments analyzed in the report, is expected to record a 17.0% CAGR and reach US$62.4 Billion by the end of the analysis period. Growth in the Hardware Component segment is estimated at 22.1% CAGR over the analysis period.

The U.S. Market is Estimated at US$11.4 Billion While China is Forecast to Grow at 25.5% CAGR

The Digital Health for Cardiovascular market in the U.S. is estimated at US$11.4 Billion in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$27.4 Billion by the year 2030 trailing a CAGR of 25.5% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 15.4% and 16.9% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 15.9% CAGR.

Global Digital Health for Cardiovascular Market - Key Trends & Drivers Summarized

Can AI and Remote Monitoring Reduce Cardiovascular Disease Burden?

The integration of digital health solutions in cardiovascular care is reshaping how heart-related diseases are managed, leveraging artificial intelligence (AI), remote patient monitoring (RPM), and wearable technologies to provide real-time insights into cardiovascular health. Cardiovascular diseases (CVDs) remain the leading cause of mortality worldwide, necessitating continuous monitoring and early intervention strategies. AI-driven algorithms are now capable of analyzing electrocardiograms (ECGs), detecting arrhythmias, and predicting potential cardiac events before they occur. Remote monitoring solutions, such as smartwatches and connected ECG patches, allow physicians to track heart rate variability, blood pressure, and irregular heart rhythms without requiring patients to visit hospitals frequently. The rise of AI-powered virtual health assistants is further improving patient engagement by offering personalized recommendations, medication reminders, and lifestyle modifications. While digital cardiovascular solutions enhance early detection and disease management, challenges such as regulatory approval, data privacy concerns, and reimbursement policies remain barriers to widespread adoption. However, as AI and remote monitoring technologies continue to improve, they are poised to transform cardiovascular care by making it more proactive, data-driven, and accessible.

How Are Digital Therapeutics (DTx) Improving Cardiovascular Outcomes?

Digital therapeutics (DTx) are emerging as a powerful tool in cardiovascular disease management, offering evidence-based, software-driven interventions to complement traditional treatments. Unlike general wellness apps, DTx solutions are clinically validated and designed to target specific cardiovascular risk factors such as hypertension, high cholesterol, and obesity. Companies like Omada Health and Livongo are developing AI-powered digital coaching programs that help patients manage lifestyle-related risk factors through behavior modification strategies. Furthermore, digital therapeutics integrated with continuous monitoring devices provide real-time alerts and intervention recommendations, reducing the risk of acute cardiac events. The shift toward value-based healthcare models is also driving insurance providers to cover digital therapeutics, making these solutions more accessible to patients. However, regulatory challenges, physician adoption hesitancy, and the need for long-term clinical validation remain obstacles to scaling DTx solutions in cardiovascular health. As research continues to demonstrate their effectiveness, digital therapeutics are expected to become a core component of cardiovascular disease prevention and management.

What Role Do AI and Big Data Play in Personalized Cardiovascular Care?

AI and big data analytics are playing an increasingly critical role in personalizing cardiovascular treatment plans, allowing for precision medicine approaches based on an individual's genetic, metabolic, and lifestyle factors. Machine learning models are being used to analyze vast datasets, including electronic health records (EHRs), genetic markers, and patient-reported data, to identify personalized treatment pathways for cardiovascular patients. AI-driven risk prediction models can stratify patients based on their likelihood of developing heart disease, enabling early intervention and targeted preventive measures. Additionally, AI-powered chatbots and telehealth platforms are improving patient engagement by providing tailored recommendations and answering cardiovascular health queries in real time. Despite the immense potential, challenges such as bias in AI models, data interoperability issues, and the need for regulatory approvals must be addressed to unlock the full capabilities of AI in cardiovascular healthcare. However, as big data continues to refine precision medicine approaches, AI is expected to play an indispensable role in optimizing cardiovascular treatment outcomes.

What Is Driving the Growth of the Digital Health for Cardiovascular Market?

The growth in the digital health for cardiovascular market is driven by several factors, including the increasing prevalence of heart diseases, rising adoption of wearable health technologies, and advancements in AI-driven diagnostics. The demand for remote patient monitoring and home-based cardiac care is surging due to the global shift toward telehealth services. Regulatory bodies are also recognizing the importance of digital health interventions, leading to increased approvals and reimbursement support for digital cardiovascular solutions. The integration of blockchain and cybersecurity measures is enhancing patient data security, increasing trust in digital health platforms. Additionally, the rise of precision medicine and personalized treatment approaches is pushing healthcare providers toward AI-powered predictive analytics in cardiovascular care. With continued investment in digital health startups and strategic partnerships among tech companies, healthcare providers, and insurers, the digital cardiovascular health market is set to experience significant growth, reshaping the future of heart disease management.

SCOPE OF STUDY:

The report analyzes the Digital Health for Cardiovascular market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Component (Software Component, Hardware Component, Service Component); End-Use (Patients End-Use, Providers End-Use, Payers End-Use, Other End-Uses)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Select Competitors (Total 42 Featured) -

  • AliveCor
  • Amwell
  • Cardiogram
  • CardioSignal
  • Cardiovascular Health Solutions
  • Cleerly
  • DarioHealth
  • Eko
  • Fitbit
  • HeartFlow
  • Hello Heart
  • Idoven
  • Lark Health
  • Medtronic
  • Omron Healthcare
  • Philips Healthcare
  • Withings
  • Neko Health
  • Story Health
  • WellDoc

AI INTEGRATIONS

We're transforming market and competitive intelligence with validated expert content and AI tools.

Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • Tariff Impact on Global Supply Chain Patterns
    • Digital Health for Cardiovascular - Global Key Competitors Percentage Market Share in 2025 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Increasing Prevalence of Cardiovascular Diseases Drives Demand for Digital Health Solutions in Cardiovascular Care
    • Surge in Remote Patient Monitoring and Telemedicine Adoption Expands Addressable Market for Cardiovascular Digital Health Technologies
    • Technological Advancements in Wearable Devices and Health Monitoring Tools Strengthen the Business Case for Digital Health in Cardiovascular Care
    • Growing Consumer Awareness of Heart Health Accelerates Adoption of Digital Health Solutions for Cardiovascular Disease Prevention
    • Rising Healthcare Costs and Need for Efficient Treatment Models Propel Demand for Digital Health Solutions in Cardiovascular Disease Management
    • Integration of Artificial Intelligence and Machine Learning in Cardiovascular Digital Health Tools Enhances Diagnosis and Treatment Planning
    • Increased Focus on Personalized Healthcare and Precision Medicine Drives Growth in Digital Health Solutions Tailored for Cardiovascular Patients
    • Expansion of Mobile Health Applications and Smartphone Integration Strengthens the Market for Cardiovascular Health Management Tools
    • The Proliferation of Big Data and Predictive Analytics in Cardiovascular Care Accelerates Adoption of Digital Health Platforms for Early Diagnosis
    • Surge in Investment by Governments and Healthcare Providers in Digital Health Infrastructure Drives Market Growth
    • The Integration of IoT in Cardiovascular Health Devices Enables Real-Time Data Collection, Expanding Market Opportunities
    • Regulatory Support for Digital Health Solutions and Remote Monitoring Devices Strengthens Market Confidence and Adoption
    • The Shift Toward Preventative Healthcare and Early Detection Strengthens Demand for Digital Health Solutions in Cardiovascular Care
    • Increasing Need for Chronic Disease Management Solutions Drives Growth in Digital Health Platforms for Long-Term Cardiovascular Care
    • Expansion of Healthcare Networks and Telehealth Programs Creates Opportunities for Cardiovascular Digital Health Solutions in Rural and Underserved Areas
    • The Growth of Cloud Computing and Data Storage Solutions in Healthcare Expands the Scalability and Reach of Digital Health Tools for Cardiovascular Care
    • The Rising Popularity of Fitness and Wellness Tracking Devices Drives Demand for Digital Health Solutions in Cardiovascular Health Management
    • Rising Incidence of Cardiovascular Disease in Aging Populations Expands the Addressable Market for Digital Cardiovascular Health Solutions
    • Regulatory Advances in Digital Health Technologies Create New Opportunities for Compliance-Driven Cardiovascular Health Solutions
    • Increased Focus on Patient Engagement and Empowerment Drives Adoption of Digital Health Tools for Cardiovascular Disease Prevention and Management
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Digital Health for Cardiovascular Market Analysis of Annual Sales in US$ Million for Years 2015 through 2030
    • TABLE 2: World Recent Past, Current & Future Analysis for Digital Health for Cardiovascular by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 3: World Historic Review for Digital Health for Cardiovascular by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 4: World 15-Year Perspective for Digital Health for Cardiovascular by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2015, 2025 & 2030
    • TABLE 5: World Recent Past, Current & Future Analysis for Software Component by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 6: World Historic Review for Software Component by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 7: World 15-Year Perspective for Software Component by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 8: World Recent Past, Current & Future Analysis for Hardware Component by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 9: World Historic Review for Hardware Component by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 10: World 15-Year Perspective for Hardware Component by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 11: World Recent Past, Current & Future Analysis for Service Component by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 12: World Historic Review for Service Component by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 13: World 15-Year Perspective for Service Component by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 14: World Recent Past, Current & Future Analysis for Patients End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 15: World Historic Review for Patients End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 16: World 15-Year Perspective for Patients End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 17: World Recent Past, Current & Future Analysis for Providers End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 18: World Historic Review for Providers End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 19: World 15-Year Perspective for Providers End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 20: World Recent Past, Current & Future Analysis for Payers End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 21: World Historic Review for Payers End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 22: World 15-Year Perspective for Payers End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 23: World Recent Past, Current & Future Analysis for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 24: World Historic Review for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 25: World 15-Year Perspective for Other End-Uses by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Digital Health for Cardiovascular Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
    • TABLE 26: USA Recent Past, Current & Future Analysis for Digital Health for Cardiovascular by Component - Software Component, Hardware Component and Service Component - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 27: USA Historic Review for Digital Health for Cardiovascular by Component - Software Component, Hardware Component and Service Component Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 28: USA 15-Year Perspective for Digital Health for Cardiovascular by Component - Percentage Breakdown of Value Sales for Software Component, Hardware Component and Service Component for the Years 2015, 2025 & 2030
    • TABLE 29: USA Recent Past, Current & Future Analysis for Digital Health for Cardiovascular by End-Use - Patients End-Use, Providers End-Use, Payers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 30: USA Historic Review for Digital Health for Cardiovascular by End-Use - Patients End-Use, Providers End-Use, Payers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 31: USA 15-Year Perspective for Digital Health for Cardiovascular by End-Use - Percentage Breakdown of Value Sales for Patients End-Use, Providers End-Use, Payers End-Use and Other End-Uses for the Years 2015, 2025 & 2030
  • CANADA
    • TABLE 32: Canada Recent Past, Current & Future Analysis for Digital Health for Cardiovascular by Component - Software Component, Hardware Component and Service Component - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 33: Canada Historic Review for Digital Health for Cardiovascular by Component - Software Component, Hardware Component and Service Component Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 34: Canada 15-Year Perspective for Digital Health for Cardiovascular by Component - Percentage Breakdown of Value Sales for Software Component, Hardware Component and Service Component for the Years 2015, 2025 & 2030
    • TABLE 35: Canada Recent Past, Current & Future Analysis for Digital Health for Cardiovascular by End-Use - Patients End-Use, Providers End-Use, Payers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 36: Canada Historic Review for Digital Health for Cardiovascular by End-Use - Patients End-Use, Providers End-Use, Payers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 37: Canada 15-Year Perspective for Digital Health for Cardiovascular by End-Use - Percentage Breakdown of Value Sales for Patients End-Use, Providers End-Use, Payers End-Use and Other End-Uses for the Years 2015, 2025 & 2030
  • JAPAN
    • Digital Health for Cardiovascular Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
    • TABLE 38: Japan Recent Past, Current & Future Analysis for Digital Health for Cardiovascular by Component - Software Component, Hardware Component and Service Component - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 39: Japan Historic Review for Digital Health for Cardiovascular by Component - Software Component, Hardware Component and Service Component Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 40: Japan 15-Year Perspective for Digital Health for Cardiovascular by Component - Percentage Breakdown of Value Sales for Software Component, Hardware Component and Service Component for the Years 2015, 2025 & 2030
    • TABLE 41: Japan Recent Past, Current & Future Analysis for Digital Health for Cardiovascular by End-Use - Patients End-Use, Providers End-Use, Payers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 42: Japan Historic Review for Digital Health for Cardiovascular by End-Use - Patients End-Use, Providers End-Use, Payers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 43: Japan 15-Year Perspective for Digital Health for Cardiovascular by End-Use - Percentage Breakdown of Value Sales for Patients End-Use, Providers End-Use, Payers End-Use and Other End-Uses for the Years 2015, 2025 & 2030
  • CHINA
    • Digital Health for Cardiovascular Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
    • TABLE 44: China Recent Past, Current & Future Analysis for Digital Health for Cardiovascular by Component - Software Component, Hardware Component and Service Component - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 45: China Historic Review for Digital Health for Cardiovascular by Component - Software Component, Hardware Component and Service Component Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 46: China 15-Year Perspective for Digital Health for Cardiovascular by Component - Percentage Breakdown of Value Sales for Software Component, Hardware Component and Service Component for the Years 2015, 2025 & 2030
    • TABLE 47: China Recent Past, Current & Future Analysis for Digital Health for Cardiovascular by End-Use - Patients End-Use, Providers End-Use, Payers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 48: China Historic Review for Digital Health for Cardiovascular by End-Use - Patients End-Use, Providers End-Use, Payers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 49: China 15-Year Perspective for Digital Health for Cardiovascular by End-Use - Percentage Breakdown of Value Sales for Patients End-Use, Providers End-Use, Payers End-Use and Other End-Uses for the Years 2015, 2025 & 2030
  • EUROPE
    • Digital Health for Cardiovascular Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
    • TABLE 50: Europe Recent Past, Current & Future Analysis for Digital Health for Cardiovascular by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 51: Europe Historic Review for Digital Health for Cardiovascular by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 52: Europe 15-Year Perspective for Digital Health for Cardiovascular by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2015, 2025 & 2030
    • TABLE 53: Europe Recent Past, Current & Future Analysis for Digital Health for Cardiovascular by Component - Software Component, Hardware Component and Service Component - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 54: Europe Historic Review for Digital Health for Cardiovascular by Component - Software Component, Hardware Component and Service Component Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 55: Europe 15-Year Perspective for Digital Health for Cardiovascular by Component - Percentage Breakdown of Value Sales for Software Component, Hardware Component and Service Component for the Years 2015, 2025 & 2030
    • TABLE 56: Europe Recent Past, Current & Future Analysis for Digital Health for Cardiovascular by End-Use - Patients End-Use, Providers End-Use, Payers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 57: Europe Historic Review for Digital Health for Cardiovascular by End-Use - Patients End-Use, Providers End-Use, Payers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 58: Europe 15-Year Perspective for Digital Health for Cardiovascular by End-Use - Percentage Breakdown of Value Sales for Patients End-Use, Providers End-Use, Payers End-Use and Other End-Uses for the Years 2015, 2025 & 2030
  • FRANCE
    • Digital Health for Cardiovascular Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
    • TABLE 59: France Recent Past, Current & Future Analysis for Digital Health for Cardiovascular by Component - Software Component, Hardware Component and Service Component - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 60: France Historic Review for Digital Health for Cardiovascular by Component - Software Component, Hardware Component and Service Component Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 61: France 15-Year Perspective for Digital Health for Cardiovascular by Component - Percentage Breakdown of Value Sales for Software Component, Hardware Component and Service Component for the Years 2015, 2025 & 2030
    • TABLE 62: France Recent Past, Current & Future Analysis for Digital Health for Cardiovascular by End-Use - Patients End-Use, Providers End-Use, Payers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 63: France Historic Review for Digital Health for Cardiovascular by End-Use - Patients End-Use, Providers End-Use, Payers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 64: France 15-Year Perspective for Digital Health for Cardiovascular by End-Use - Percentage Breakdown of Value Sales for Patients End-Use, Providers End-Use, Payers End-Use and Other End-Uses for the Years 2015, 2025 & 2030
  • GERMANY
    • Digital Health for Cardiovascular Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
    • TABLE 65: Germany Recent Past, Current & Future Analysis for Digital Health for Cardiovascular by Component - Software Component, Hardware Component and Service Component - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 66: Germany Historic Review for Digital Health for Cardiovascular by Component - Software Component, Hardware Component and Service Component Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 67: Germany 15-Year Perspective for Digital Health for Cardiovascular by Component - Percentage Breakdown of Value Sales for Software Component, Hardware Component and Service Component for the Years 2015, 2025 & 2030
    • TABLE 68: Germany Recent Past, Current & Future Analysis for Digital Health for Cardiovascular by End-Use - Patients End-Use, Providers End-Use, Payers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 69: Germany Historic Review for Digital Health for Cardiovascular by End-Use - Patients End-Use, Providers End-Use, Payers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 70: Germany 15-Year Perspective for Digital Health for Cardiovascular by End-Use - Percentage Breakdown of Value Sales for Patients End-Use, Providers End-Use, Payers End-Use and Other End-Uses for the Years 2015, 2025 & 2030
  • ITALY
    • TABLE 71: Italy Recent Past, Current & Future Analysis for Digital Health for Cardiovascular by Component - Software Component, Hardware Component and Service Component - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 72: Italy Historic Review for Digital Health for Cardiovascular by Component - Software Component, Hardware Component and Service Component Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 73: Italy 15-Year Perspective for Digital Health for Cardiovascular by Component - Percentage Breakdown of Value Sales for Software Component, Hardware Component and Service Component for the Years 2015, 2025 & 2030
    • TABLE 74: Italy Recent Past, Current & Future Analysis for Digital Health for Cardiovascular by End-Use - Patients End-Use, Providers End-Use, Payers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 75: Italy Historic Review for Digital Health for Cardiovascular by End-Use - Patients End-Use, Providers End-Use, Payers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 76: Italy 15-Year Perspective for Digital Health for Cardiovascular by End-Use - Percentage Breakdown of Value Sales for Patients End-Use, Providers End-Use, Payers End-Use and Other End-Uses for the Years 2015, 2025 & 2030
  • UNITED KINGDOM
    • Digital Health for Cardiovascular Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
    • TABLE 77: UK Recent Past, Current & Future Analysis for Digital Health for Cardiovascular by Component - Software Component, Hardware Component and Service Component - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 78: UK Historic Review for Digital Health for Cardiovascular by Component - Software Component, Hardware Component and Service Component Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 79: UK 15-Year Perspective for Digital Health for Cardiovascular by Component - Percentage Breakdown of Value Sales for Software Component, Hardware Component and Service Component for the Years 2015, 2025 & 2030
    • TABLE 80: UK Recent Past, Current & Future Analysis for Digital Health for Cardiovascular by End-Use - Patients End-Use, Providers End-Use, Payers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 81: UK Historic Review for Digital Health for Cardiovascular by End-Use - Patients End-Use, Providers End-Use, Payers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 82: UK 15-Year Perspective for Digital Health for Cardiovascular by End-Use - Percentage Breakdown of Value Sales for Patients End-Use, Providers End-Use, Payers End-Use and Other End-Uses for the Years 2015, 2025 & 2030
  • SPAIN
    • TABLE 83: Spain Recent Past, Current & Future Analysis for Digital Health for Cardiovascular by Component - Software Component, Hardware Component and Service Component - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 84: Spain Historic Review for Digital Health for Cardiovascular by Component - Software Component, Hardware Component and Service Component Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 85: Spain 15-Year Perspective for Digital Health for Cardiovascular by Component - Percentage Breakdown of Value Sales for Software Component, Hardware Component and Service Component for the Years 2015, 2025 & 2030
    • TABLE 86: Spain Recent Past, Current & Future Analysis for Digital Health for Cardiovascular by End-Use - Patients End-Use, Providers End-Use, Payers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 87: Spain Historic Review for Digital Health for Cardiovascular by End-Use - Patients End-Use, Providers End-Use, Payers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 88: Spain 15-Year Perspective for Digital Health for Cardiovascular by End-Use - Percentage Breakdown of Value Sales for Patients End-Use, Providers End-Use, Payers End-Use and Other End-Uses for the Years 2015, 2025 & 2030
  • RUSSIA
    • TABLE 89: Russia Recent Past, Current & Future Analysis for Digital Health for Cardiovascular by Component - Software Component, Hardware Component and Service Component - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 90: Russia Historic Review for Digital Health for Cardiovascular by Component - Software Component, Hardware Component and Service Component Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 91: Russia 15-Year Perspective for Digital Health for Cardiovascular by Component - Percentage Breakdown of Value Sales for Software Component, Hardware Component and Service Component for the Years 2015, 2025 & 2030
    • TABLE 92: Russia Recent Past, Current & Future Analysis for Digital Health for Cardiovascular by End-Use - Patients End-Use, Providers End-Use, Payers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 93: Russia Historic Review for Digital Health for Cardiovascular by End-Use - Patients End-Use, Providers End-Use, Payers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 94: Russia 15-Year Perspective for Digital Health for Cardiovascular by End-Use - Percentage Breakdown of Value Sales for Patients End-Use, Providers End-Use, Payers End-Use and Other End-Uses for the Years 2015, 2025 & 2030
  • REST OF EUROPE
    • TABLE 95: Rest of Europe Recent Past, Current & Future Analysis for Digital Health for Cardiovascular by Component - Software Component, Hardware Component and Service Component - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 96: Rest of Europe Historic Review for Digital Health for Cardiovascular by Component - Software Component, Hardware Component and Service Component Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 97: Rest of Europe 15-Year Perspective for Digital Health for Cardiovascular by Component - Percentage Breakdown of Value Sales for Software Component, Hardware Component and Service Component for the Years 2015, 2025 & 2030
    • TABLE 98: Rest of Europe Recent Past, Current & Future Analysis for Digital Health for Cardiovascular by End-Use - Patients End-Use, Providers End-Use, Payers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 99: Rest of Europe Historic Review for Digital Health for Cardiovascular by End-Use - Patients End-Use, Providers End-Use, Payers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 100: Rest of Europe 15-Year Perspective for Digital Health for Cardiovascular by End-Use - Percentage Breakdown of Value Sales for Patients End-Use, Providers End-Use, Payers End-Use and Other End-Uses for the Years 2015, 2025 & 2030
  • ASIA-PACIFIC
    • Digital Health for Cardiovascular Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
    • TABLE 101: Asia-Pacific Recent Past, Current & Future Analysis for Digital Health for Cardiovascular by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 102: Asia-Pacific Historic Review for Digital Health for Cardiovascular by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 103: Asia-Pacific 15-Year Perspective for Digital Health for Cardiovascular by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2015, 2025 & 2030
    • TABLE 104: Asia-Pacific Recent Past, Current & Future Analysis for Digital Health for Cardiovascular by Component - Software Component, Hardware Component and Service Component - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 105: Asia-Pacific Historic Review for Digital Health for Cardiovascular by Component - Software Component, Hardware Component and Service Component Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 106: Asia-Pacific 15-Year Perspective for Digital Health for Cardiovascular by Component - Percentage Breakdown of Value Sales for Software Component, Hardware Component and Service Component for the Years 2015, 2025 & 2030
    • TABLE 107: Asia-Pacific Recent Past, Current & Future Analysis for Digital Health for Cardiovascular by End-Use - Patients End-Use, Providers End-Use, Payers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 108: Asia-Pacific Historic Review for Digital Health for Cardiovascular by End-Use - Patients End-Use, Providers End-Use, Payers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 109: Asia-Pacific 15-Year Perspective for Digital Health for Cardiovascular by End-Use - Percentage Breakdown of Value Sales for Patients End-Use, Providers End-Use, Payers End-Use and Other End-Uses for the Years 2015, 2025 & 2030
  • AUSTRALIA
    • Digital Health for Cardiovascular Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2025 (E)
    • TABLE 110: Australia Recent Past, Current & Future Analysis for Digital Health for Cardiovascular by Component - Software Component, Hardware Component and Service Component - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 111: Australia Historic Review for Digital Health for Cardiovascular by Component - Software Component, Hardware Component and Service Component Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 112: Australia 15-Year Perspective for Digital Health for Cardiovascular by Component - Percentage Breakdown of Value Sales for Software Component, Hardware Component and Service Component for the Years 2015, 2025 & 2030
    • TABLE 113: Australia Recent Past, Current & Future Analysis for Digital Health for Cardiovascular by End-Use - Patients End-Use, Providers End-Use, Payers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 114: Australia Historic Review for Digital Health for Cardiovascular by End-Use - Patients End-Use, Providers End-Use, Payers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 115: Australia 15-Year Perspective for Digital Health for Cardiovascular by End-Use - Percentage Breakdown of Value Sales for Patients End-Use, Providers End-Use, Payers End-Use and Other End-Uses for the Years 2015, 2025 & 2030
  • INDIA
    • Digital Health for Cardiovascular Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2025 (E)
    • TABLE 116: India Recent Past, Current & Future Analysis for Digital Health for Cardiovascular by Component - Software Component, Hardware Component and Service Component - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 117: India Historic Review for Digital Health for Cardiovascular by Component - Software Component, Hardware Component and Service Component Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 118: India 15-Year Perspective for Digital Health for Cardiovascular by Component - Percentage Breakdown of Value Sales for Software Component, Hardware Component and Service Component for the Years 2015, 2025 & 2030
    • TABLE 119: India Recent Past, Current & Future Analysis for Digital Health for Cardiovascular by End-Use - Patients End-Use, Providers End-Use, Payers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 120: India Historic Review for Digital Health for Cardiovascular by End-Use - Patients End-Use, Providers End-Use, Payers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 121: India 15-Year Perspective for Digital Health for Cardiovascular by End-Use - Percentage Breakdown of Value Sales for Patients End-Use, Providers End-Use, Payers End-Use and Other End-Uses for the Years 2015, 2025 & 2030
  • SOUTH KOREA
    • TABLE 122: South Korea Recent Past, Current & Future Analysis for Digital Health for Cardiovascular by Component - Software Component, Hardware Component and Service Component - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 123: South Korea Historic Review for Digital Health for Cardiovascular by Component - Software Component, Hardware Component and Service Component Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 124: South Korea 15-Year Perspective for Digital Health for Cardiovascular by Component - Percentage Breakdown of Value Sales for Software Component, Hardware Component and Service Component for the Years 2015, 2025 & 2030
    • TABLE 125: South Korea Recent Past, Current & Future Analysis for Digital Health for Cardiovascular by End-Use - Patients End-Use, Providers End-Use, Payers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 126: South Korea Historic Review for Digital Health for Cardiovascular by End-Use - Patients End-Use, Providers End-Use, Payers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 127: South Korea 15-Year Perspective for Digital Health for Cardiovascular by End-Use - Percentage Breakdown of Value Sales for Patients End-Use, Providers End-Use, Payers End-Use and Other End-Uses for the Years 2015, 2025 & 2030
  • REST OF ASIA-PACIFIC
    • TABLE 128: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Digital Health for Cardiovascular by Component - Software Component, Hardware Component and Service Component - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 129: Rest of Asia-Pacific Historic Review for Digital Health for Cardiovascular by Component - Software Component, Hardware Component and Service Component Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 130: Rest of Asia-Pacific 15-Year Perspective for Digital Health for Cardiovascular by Component - Percentage Breakdown of Value Sales for Software Component, Hardware Component and Service Component for the Years 2015, 2025 & 2030
    • TABLE 131: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Digital Health for Cardiovascular by End-Use - Patients End-Use, Providers End-Use, Payers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 132: Rest of Asia-Pacific Historic Review for Digital Health for Cardiovascular by End-Use - Patients End-Use, Providers End-Use, Payers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 133: Rest of Asia-Pacific 15-Year Perspective for Digital Health for Cardiovascular by End-Use - Percentage Breakdown of Value Sales for Patients End-Use, Providers End-Use, Payers End-Use and Other End-Uses for the Years 2015, 2025 & 2030
  • LATIN AMERICA
    • Digital Health for Cardiovascular Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2025 (E)
    • TABLE 134: Latin America Recent Past, Current & Future Analysis for Digital Health for Cardiovascular by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 135: Latin America Historic Review for Digital Health for Cardiovascular by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 136: Latin America 15-Year Perspective for Digital Health for Cardiovascular by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2015, 2025 & 2030
    • TABLE 137: Latin America Recent Past, Current & Future Analysis for Digital Health for Cardiovascular by Component - Software Component, Hardware Component and Service Component - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 138: Latin America Historic Review for Digital Health for Cardiovascular by Component - Software Component, Hardware Component and Service Component Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 139: Latin America 15-Year Perspective for Digital Health for Cardiovascular by Component - Percentage Breakdown of Value Sales for Software Component, Hardware Component and Service Component for the Years 2015, 2025 & 2030
    • TABLE 140: Latin America Recent Past, Current & Future Analysis for Digital Health for Cardiovascular by End-Use - Patients End-Use, Providers End-Use, Payers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 141: Latin America Historic Review for Digital Health for Cardiovascular by End-Use - Patients End-Use, Providers End-Use, Payers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 142: Latin America 15-Year Perspective for Digital Health for Cardiovascular by End-Use - Percentage Breakdown of Value Sales for Patients End-Use, Providers End-Use, Payers End-Use and Other End-Uses for the Years 2015, 2025 & 2030
  • ARGENTINA
    • TABLE 143: Argentina Recent Past, Current & Future Analysis for Digital Health for Cardiovascular by Component - Software Component, Hardware Component and Service Component - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 144: Argentina Historic Review for Digital Health for Cardiovascular by Component - Software Component, Hardware Component and Service Component Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 145: Argentina 15-Year Perspective for Digital Health for Cardiovascular by Component - Percentage Breakdown of Value Sales for Software Component, Hardware Component and Service Component for the Years 2015, 2025 & 2030
    • TABLE 146: Argentina Recent Past, Current & Future Analysis for Digital Health for Cardiovascular by End-Use - Patients End-Use, Providers End-Use, Payers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 147: Argentina Historic Review for Digital Health for Cardiovascular by End-Use - Patients End-Use, Providers End-Use, Payers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 148: Argentina 15-Year Perspective for Digital Health for Cardiovascular by End-Use - Percentage Breakdown of Value Sales for Patients End-Use, Providers End-Use, Payers End-Use and Other End-Uses for the Years 2015, 2025 & 2030
  • BRAZIL
    • TABLE 149: Brazil Recent Past, Current & Future Analysis for Digital Health for Cardiovascular by Component - Software Component, Hardware Component and Service Component - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 150: Brazil Historic Review for Digital Health for Cardiovascular by Component - Software Component, Hardware Component and Service Component Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 151: Brazil 15-Year Perspective for Digital Health for Cardiovascular by Component - Percentage Breakdown of Value Sales for Software Component, Hardware Component and Service Component for the Years 2015, 2025 & 2030
    • TABLE 152: Brazil Recent Past, Current & Future Analysis for Digital Health for Cardiovascular by End-Use - Patients End-Use, Providers End-Use, Payers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 153: Brazil Historic Review for Digital Health for Cardiovascular by End-Use - Patients End-Use, Providers End-Use, Payers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 154: Brazil 15-Year Perspective for Digital Health for Cardiovascular by End-Use - Percentage Breakdown of Value Sales for Patients End-Use, Providers End-Use, Payers End-Use and Other End-Uses for the Years 2015, 2025 & 2030
  • MEXICO
    • TABLE 155: Mexico Recent Past, Current & Future Analysis for Digital Health for Cardiovascular by Component - Software Component, Hardware Component and Service Component - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 156: Mexico Historic Review for Digital Health for Cardiovascular by Component - Software Component, Hardware Component and Service Component Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 157: Mexico 15-Year Perspective for Digital Health for Cardiovascular by Component - Percentage Breakdown of Value Sales for Software Component, Hardware Component and Service Component for the Years 2015, 2025 & 2030
    • TABLE 158: Mexico Recent Past, Current & Future Analysis for Digital Health for Cardiovascular by End-Use - Patients End-Use, Providers End-Use, Payers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 159: Mexico Historic Review for Digital Health for Cardiovascular by End-Use - Patients End-Use, Providers End-Use, Payers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 160: Mexico 15-Year Perspective for Digital Health for Cardiovascular by End-Use - Percentage Breakdown of Value Sales for Patients End-Use, Providers End-Use, Payers End-Use and Other End-Uses for the Years 2015, 2025 & 2030
  • REST OF LATIN AMERICA
    • TABLE 161: Rest of Latin America Recent Past, Current & Future Analysis for Digital Health for Cardiovascular by Component - Software Component, Hardware Component and Service Component - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 162: Rest of Latin America Historic Review for Digital Health for Cardiovascular by Component - Software Component, Hardware Component and Service Component Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 163: Rest of Latin America 15-Year Perspective for Digital Health for Cardiovascular by Component - Percentage Breakdown of Value Sales for Software Component, Hardware Component and Service Component for the Years 2015, 2025 & 2030
    • TABLE 164: Rest of Latin America Recent Past, Current & Future Analysis for Digital Health for Cardiovascular by End-Use - Patients End-Use, Providers End-Use, Payers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 165: Rest of Latin America Historic Review for Digital Health for Cardiovascular by End-Use - Patients End-Use, Providers End-Use, Payers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 166: Rest of Latin America 15-Year Perspective for Digital Health for Cardiovascular by End-Use - Percentage Breakdown of Value Sales for Patients End-Use, Providers End-Use, Payers End-Use and Other End-Uses for the Years 2015, 2025 & 2030
  • MIDDLE EAST
    • Digital Health for Cardiovascular Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2025 (E)
    • TABLE 167: Middle East Recent Past, Current & Future Analysis for Digital Health for Cardiovascular by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 168: Middle East Historic Review for Digital Health for Cardiovascular by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 169: Middle East 15-Year Perspective for Digital Health for Cardiovascular by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2015, 2025 & 2030
    • TABLE 170: Middle East Recent Past, Current & Future Analysis for Digital Health for Cardiovascular by Component - Software Component, Hardware Component and Service Component - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 171: Middle East Historic Review for Digital Health for Cardiovascular by Component - Software Component, Hardware Component and Service Component Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 172: Middle East 15-Year Perspective for Digital Health for Cardiovascular by Component - Percentage Breakdown of Value Sales for Software Component, Hardware Component and Service Component for the Years 2015, 2025 & 2030
    • TABLE 173: Middle East Recent Past, Current & Future Analysis for Digital Health for Cardiovascular by End-Use - Patients End-Use, Providers End-Use, Payers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 174: Middle East Historic Review for Digital Health for Cardiovascular by End-Use - Patients End-Use, Providers End-Use, Payers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 175: Middle East 15-Year Perspective for Digital Health for Cardiovascular by End-Use - Percentage Breakdown of Value Sales for Patients End-Use, Providers End-Use, Payers End-Use and Other End-Uses for the Years 2015, 2025 & 2030
  • IRAN
    • TABLE 176: Iran Recent Past, Current & Future Analysis for Digital Health for Cardiovascular by Component - Software Component, Hardware Component and Service Component - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 177: Iran Historic Review for Digital Health for Cardiovascular by Component - Software Component, Hardware Component and Service Component Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 178: Iran 15-Year Perspective for Digital Health for Cardiovascular by Component - Percentage Breakdown of Value Sales for Software Component, Hardware Component and Service Component for the Years 2015, 2025 & 2030
    • TABLE 179: Iran Recent Past, Current & Future Analysis for Digital Health for Cardiovascular by End-Use - Patients End-Use, Providers End-Use, Payers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 180: Iran Historic Review for Digital Health for Cardiovascular by End-Use - Patients End-Use, Providers End-Use, Payers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 181: Iran 15-Year Perspective for Digital Health for Cardiovascular by End-Use - Percentage Breakdown of Value Sales for Patients End-Use, Providers End-Use, Payers End-Use and Other End-Uses for the Years 2015, 2025 & 2030
  • ISRAEL
    • TABLE 182: Israel Recent Past, Current & Future Analysis for Digital Health for Cardiovascular by Component - Software Component, Hardware Component and Service Component - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 183: Israel Historic Review for Digital Health for Cardiovascular by Component - Software Component, Hardware Component and Service Component Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 184: Israel 15-Year Perspective for Digital Health for Cardiovascular by Component - Percentage Breakdown of Value Sales for Software Component, Hardware Component and Service Component for the Years 2015, 2025 & 2030
    • TABLE 185: Israel Recent Past, Current & Future Analysis for Digital Health for Cardiovascular by End-Use - Patients End-Use, Providers End-Use, Payers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 186: Israel Historic Review for Digital Health for Cardiovascular by End-Use - Patients End-Use, Providers End-Use, Payers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 187: Israel 15-Year Perspective for Digital Health for Cardiovascular by End-Use - Percentage Breakdown of Value Sales for Patients End-Use, Providers End-Use, Payers End-Use and Other End-Uses for the Years 2015, 2025 & 2030
  • SAUDI ARABIA
    • TABLE 188: Saudi Arabia Recent Past, Current & Future Analysis for Digital Health for Cardiovascular by Component - Software Component, Hardware Component and Service Component - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 189: Saudi Arabia Historic Review for Digital Health for Cardiovascular by Component - Software Component, Hardware Component and Service Component Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 190: Saudi Arabia 15-Year Perspective for Digital Health for Cardiovascular by Component - Percentage Breakdown of Value Sales for Software Component, Hardware Component and Service Component for the Years 2015, 2025 & 2030
    • TABLE 191: Saudi Arabia Recent Past, Current & Future Analysis for Digital Health for Cardiovascular by End-Use - Patients End-Use, Providers End-Use, Payers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 192: Saudi Arabia Historic Review for Digital Health for Cardiovascular by End-Use - Patients End-Use, Providers End-Use, Payers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 193: Saudi Arabia 15-Year Perspective for Digital Health for Cardiovascular by End-Use - Percentage Breakdown of Value Sales for Patients End-Use, Providers End-Use, Payers End-Use and Other End-Uses for the Years 2015, 2025 & 2030
  • UNITED ARAB EMIRATES
    • TABLE 194: UAE Recent Past, Current & Future Analysis for Digital Health for Cardiovascular by Component - Software Component, Hardware Component and Service Component - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 195: UAE Historic Review for Digital Health for Cardiovascular by Component - Software Component, Hardware Component and Service Component Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 196: UAE 15-Year Perspective for Digital Health for Cardiovascular by Component - Percentage Breakdown of Value Sales for Software Component, Hardware Component and Service Component for the Years 2015, 2025 & 2030
    • TABLE 197: UAE Recent Past, Current & Future Analysis for Digital Health for Cardiovascular by End-Use - Patients End-Use, Providers End-Use, Payers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 198: UAE Historic Review for Digital Health for Cardiovascular by End-Use - Patients End-Use, Providers End-Use, Payers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 199: UAE 15-Year Perspective for Digital Health for Cardiovascular by End-Use - Percentage Breakdown of Value Sales for Patients End-Use, Providers End-Use, Payers End-Use and Other End-Uses for the Years 2015, 2025 & 2030
  • REST OF MIDDLE EAST
    • TABLE 200: Rest of Middle East Recent Past, Current & Future Analysis for Digital Health for Cardiovascular by Component - Software Component, Hardware Component and Service Component - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 201: Rest of Middle East Historic Review for Digital Health for Cardiovascular by Component - Software Component, Hardware Component and Service Component Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 202: Rest of Middle East 15-Year Perspective for Digital Health for Cardiovascular by Component - Percentage Breakdown of Value Sales for Software Component, Hardware Component and Service Component for the Years 2015, 2025 & 2030
    • TABLE 203: Rest of Middle East Recent Past, Current & Future Analysis for Digital Health for Cardiovascular by End-Use - Patients End-Use, Providers End-Use, Payers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 204: Rest of Middle East Historic Review for Digital Health for Cardiovascular by End-Use - Patients End-Use, Providers End-Use, Payers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 205: Rest of Middle East 15-Year Perspective for Digital Health for Cardiovascular by End-Use - Percentage Breakdown of Value Sales for Patients End-Use, Providers End-Use, Payers End-Use and Other End-Uses for the Years 2015, 2025 & 2030
  • AFRICA
    • Digital Health for Cardiovascular Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2025 (E)
    • TABLE 206: Africa Recent Past, Current & Future Analysis for Digital Health for Cardiovascular by Component - Software Component, Hardware Component and Service Component - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 207: Africa Historic Review for Digital Health for Cardiovascular by Component - Software Component, Hardware Component and Service Component Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 208: Africa 15-Year Perspective for Digital Health for Cardiovascular by Component - Percentage Breakdown of Value Sales for Software Component, Hardware Component and Service Component for the Years 2015, 2025 & 2030
    • TABLE 209: Africa Recent Past, Current & Future Analysis for Digital Health for Cardiovascular by End-Use - Patients End-Use, Providers End-Use, Payers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 210: Africa Historic Review for Digital Health for Cardiovascular by End-Use - Patients End-Use, Providers End-Use, Payers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 211: Africa 15-Year Perspective for Digital Health for Cardiovascular by End-Use - Percentage Breakdown of Value Sales for Patients End-Use, Providers End-Use, Payers End-Use and Other End-Uses for the Years 2015, 2025 & 2030

IV. COMPETITION